Immunocore Holdings (IMCR) Stock Statistics & Valuation Metrics

Immunocore Holdings has a market cap or net worth of $1.36B. The enterprise value is $1.22B.

Immunocore Holdings has 50.07M shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunocore Holdings’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -8.50%.

The current PE Ratio of Immunocore Holdings is -28.87. Immunocore Holdings’s PEG ratio is 2.97.

In the last 12 months, Immunocore Holdings had revenue of $310.20M and earned -$51.09M in profits. Earnings per share was -$1.02.

In the last 12 months, operating cash flow was $26.06M and capital expenditures -$5.17M, giving a free cash flow of $20.89M billion.

Immunocore Holdings pays an annual dividend of , resulting in a dividend yield of

Immunocore Holdings upcoming earnings date is May 7, 2025, Before Open.

Immunocore Holdings as a current ratio of 4.38, with Debt / Equity ratio of 0.12

In the past 12 months, Immunocore Holdings has paid -$1.85M in taxes.

Immunocore Holdings EV to EBITDA ratio is -15.05, with an EV/FCF ratio of 50.78.

Immunocore Holdings has $820.38M in cash and marketable securities with $432.72M in debt, giving a net cash position of -$387.65M billion.

Gross margin is 99.12%, with operating margin of -22.71%, and net profit margin of -16.47%.

The average price target for Immunocore Holdings is $68.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy